Predictive validity of the EuropASI: Clinical diagnosis or composite scoring?

Abstract

This study assessed the correlation between the areas of the interviewer severity rating (ISR) and the areas of the composite scores (CSs) of the European version of the Addiction Severity Index (EuropASI). It evaluated the predictive validity of both types of scoring with regard to completion of treatment. For this purpose, 252 patients were interviewed using the EuropASI; 38.9% of patients discontinued treatment. Results indicated a high correlation between various areas of the ISR and the CS, except the legal and family-others scales. Regarding predictive results, patients with a score greater than 3 in the ISR family area were more likely to quit the program compared with patients with a score lower than 3. Patients with a CS score that was greater than 0.34 in the alcohol use area were more likely to drop out of treatment. When both ISR and CS scores were included in the prediction model, the ISR family area was a better predictor.

Gender differences in drug-addicted patients in a clinical treatment center of Spain

“…The Spanish version of the EuropASI was developed by Bobes, González, Sáiz and Bousoño . In this study, ISR and CS have been used, because they offer complementary information . The short‐term test–retest reliabilities of the ASI severity ratings have been reported to be greater than or equal to .92 for all domains .…”

Suicidal ideation and attempts among patients with lifetime physical and/or sexual abuse in treatment for substance use disorders

“…This interview assesses the need for patient treatment based on seven relationships; and g) psychological state. The Interviewer Severity Rating (ISR), which has proven useful in several studies conducted in the treatment context (López-Goñi, Fernández-Montalvo, & Arteaga, 2012;López-Goñi et al, 2010), was used in this study. The score for each area ranges from 0 (no problem) to 9 (extreme problem).…”

Profile of Addicted Patients who Reenter Treatment Programs

“…Various studies have suggested that patients who abandon treatment prematurely (regardless of the treatment period in question) present with, among other factors, more anxiety problems, (24) more severe addictions, (6,25) greater cognitive deficits, (26,27) more personality disorders, (25.28) greater psychopathological problems, (29) less social or familial support, or different combinations of these factors. (4,30) The combination of withdrawal from a previous treatment program and the presence of a more severe addiction profile requires that the protocols that are used in the treatment of a readmitted patient have specific adaptations that are designed to make therapeutic interventions more efficient.…”